期刊文献+

FBL3细胞在小鼠体内外诱导CD4^+CD25^+调节性T细胞增殖的实验研究

The experimental study on proliferation of CD4^+CD25^+ regulatory T cells in mice and in vitro induced by FBL3 cells
在线阅读 下载PDF
导出
摘要 目的:通过小鼠体内外实验观察肿瘤细胞是否可以诱导CD4+CD25+Treg的分化增殖。方法:将小鼠的红白血病瘤细胞系FBL3接种于C57BL/6小鼠腹壁皮下,流式细胞仪检测小鼠外周血、脾脏及瘤组织CD4+CD25+Treg细胞含量,RT-PCR检测小鼠脾脏及瘤组织Foxp3 mRNA的表达;体外实验检测FBL3细胞培养上清液对小鼠脾脏CD4+CD25+Treg细胞的作用。结果:荷瘤鼠外周血CD4+CD25+Treg比例与正常鼠比较无统计学差异(P>0.05),但荷瘤鼠脾脏CD4+CD25+Treg比例显著高于正常对照(P<0.01),荷瘤小鼠脾脏组织Foxp3 mRNA的表达量明显增加;体外实验表明FBL3培养上清液促使CD4+CD25+Treg细胞比例增高,并诱导Foxp3 mRNA表达增加。结论:FBL3细胞及其分泌的可溶性物质能诱导CD4+CD25+Treg细胞的增殖,说明是肿瘤的发生促进了CD4+CD25+Treg增高。 Objective: To explore if the tumor cells could induce the proliferation of CD4^+CD25^+ Treg in mice by in vitro and in vivo. Methods:The erythroleukemic cell line FBL3 cells were inoculated at abdominal cavity. CD4^+CD25^+ subset in peripheral blood and spleen lymphocytes was analyzed by flow cytometry;The level of Foxp3 mRNA was tested by RT-PCR; In vitro experiments were used to see if the supernatant medium of cultured leukemia cell line FBL3 could affect the proliferation of CD4^+CD25^+ Treg cells.Results:No difference was observed in the proportion of CD4^+CD25^+ Treg cells in peripheral blood lymphocytes between tumor-bearing mice and normal mice( P 〉 0.05), while the proportion of CD4^+CD25^+ Treg cells in spleens of tumor-bearing mice was increased significantly compared with that of normal mice (P 〈 0.01).The level of Foxp3 mRNA in spleens of tumor-bearing mice was significantly higher than that of the control. It was indicated that the supernatant derived from FBL3 upregulated the proportion of CD4^+CD25^+ Treg cells and the level of corresponding Foxp3 mRNA in vitro. Conclnsion:The leukemic cells and their solube factors can induce the increase of CD4^+CD25^+ Treg and tumorigenesis may facilitate the pro- liferation of CD4^+CD25^+ Treg cells.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第6期518-520,525,共4页 Chinese Journal of Immunology
基金 山西医科大学博士启动基金资助
关键词 CD4阳性T淋巴细胞 肿瘤 FOXP3 MRNA CD4-positive T-lymphocytes Tumor Foxp3 mRNA
作者简介 张帆(1971年-),女,博士,讲师,主要从事肿瘤免疫研究,E-mail:zhangfan11688@126.com; 通讯作者及指导教师:王宏伟(1966年-),男,博士,教授,博士生导师,主要从事白血病分子生物学研究,E-mail:wanghw68@hotmail.com。
  • 相关文献

参考文献9

  • 1Beyer M, Schultze J L. Regulatory T cells in cancer [ J ]. Blood, 2006; 108 (3):804-811.
  • 2Liu J Y,Zhang X S, Ding Y et al. The changes of CD4^+ CD25^+/CD4^+ proportion in spleen of tumor-bearing BALB/c mice[J]. J Transl Med, 2005;3(1) :5-8.
  • 3Tien A H, Xu L, Helgason C D et al. Altered immunity accompanies disease progresssion in a mouse model of prostate dysplasia[J]. Cancer Res, 2005; 65 (7) : 2947-2955.
  • 4Linehan D C, Goedegebuure P S. CD25 ^+ CD4 ^+ regulatory T cells in cancer [J]. Immunol Res,2005;32(1-3) : 155-168.
  • 5Hori S, Nomum T, Sakaguehi Set al. Control of regulatory T cells development by the transcription factor Foxp3 [ J ]. Science, 2003 ; 299 (5609) : 1057-1061.
  • 6Khattri R, Kasprowicz D, Cox T et al. The amount of scurfin protein determines peripheral T cell number and responsiveness[J]. J Immunol, 2001; 167(11) :6312-6320.
  • 7Hontsu S, Yoneyama H, Ueha S et al. Visualization of naturally occurring Foxp3 + regulatory T cells in normal and tumor-bearing mice[J]. Int Immunopharmacol, 2004;4(14) : 1785-1793.
  • 8李晓,陈怀增,谢幸,叶大风,吕卫国,丁志明.卵巢癌患者CD4^+CD25^+调节性T细胞比例增高的可能机制[J].中华微生物学和免疫学杂志,2004,24(7):538-539. 被引量:10
  • 9李晓,陈怀增,叶枫,吕卫国,洪蝶,陈小君,谢幸.卵巢癌细胞培养上清诱导CD4^+CD25^-T细胞分化为CD4^+CD25^+调节性T细胞[J].中华微生物学和免疫学杂志,2006,26(2):121-124. 被引量:5

二级参考文献11

  • 1Thornton AM, Shevach EM. CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med, 1998, 188(2): 287-296.
  • 2Piccirillo CA, Shevah EM. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol, 2001, 167(3): 1137-1140.
  • 3Seo N, Hayakawa S, Takigawa M, et al. Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity. Immunology, 2001, 103(4):449-457.
  • 4Steitz J, Bruck J, Lenz J, et al. Depletion of CD25 + CD4 + T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon α-induced, CD8 + T cell dependent immune defense of B 16 melanoma. Cancer Res, 2001, 61(
  • 5Itoh M,Takahashi T,Sakaguchi N,et al.Thymus and autoimmunity:production of CD25^ + CD4 ^+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.J Immunol,1999,162(9):5317-5326.
  • 6Woo EY,Chu CS,Golez TJ,et al.Regulatory CD4^ + CD25^ + T cells in tumors from patients with early-stage non-small cell lung cancer and latestage ovarian cancer.Cancer Res,2001,61(12):4766-4772.
  • 7Li X,Ye DF,Xie X,et al.Increase of CD4 ^+ CD25^ + regulatory T cell in the patients with ovarian carcinoma.Cancer Invest,2005,23 (5):399-403.
  • 8Apostolou I,Sarukhan A,Klein L,et al.Origin of regulatory T cells with known specificity for antigen.Nat Immunol,2002,3(8):756-763.
  • 9Levings MK,Sangregorio R,Sartirana C,et al.Human CD25^ + CD4^ + T suppressor cell clones produce transforming growth,but not interleukin 10,and are distinct from type 1 T regulatory cells.J Exp Med,2002,196(10):1335-1346.
  • 10Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4 ^+ CD25 ^+ regulatory T cells.Nat Immunol,2003,4(4):330-336.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部